Are We Ready for Systematic Newborn Genome Sequencing?

Routine sampling and analysis of newborn DNA would enable screening for hundreds of childhood genetic diseases, but also raises concerns about privacy and ethics.

Related Keywords

Italy ,Belgium ,Philadelphia ,Pennsylvania ,United States ,Boston ,Massachusetts ,New York ,United Kingdom ,Paris ,France General ,France ,North Carolina ,American ,French ,Robert Guthrie ,Pascal Pujol ,David Genevi ,Newborn Genomes Programme ,French Association Of Clinical Geneticists ,University Of Montpellier ,Current International Trials ,French Society Of Predictive ,Dijon Specialist Team ,French Association ,Clinical Geneticists ,French Society ,Personalized Medicine ,Babyseq Project ,Early Check ,Genomics England ,Genomics ,Genomic Medicine ,Edicine Genomic ,Newborn ,Neonate ,Newborn Screening ,Genetics ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Childhood Screening ,Genetic Testing ,Birth ,Muscular Atrophy ,Uscular Atrophies ,Pregnancy ,Preventive Screening ,Screening ,Rare Diseases ,Spinal Muscular Atrophy ,Spinal Muscle Atrophy ,Dna Sequencing ,Ethics ,Hypothyroidism ,Thyroid Disorder ,Sickle Cell ,